204 related articles for article (PubMed ID: 11874898)
41. [Meningococcal vaccines: present status and perspectives].
Alonso JM; Taha MK
Therapie; 2005; 60(3):283-6. PubMed ID: 16128272
[TBL] [Abstract][Full Text] [Related]
42. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.
Griffiss JM; Brandt BL; Altieri PL; Pier GB; Berman SL
Infect Immun; 1981 Dec; 34(3):725-32. PubMed ID: 6800954
[TBL] [Abstract][Full Text] [Related]
43. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
Snape MD; Perrett KP; Ford KJ; John TM; Pace D; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
JAMA; 2008 Jan; 299(2):173-84. PubMed ID: 18182599
[TBL] [Abstract][Full Text] [Related]
44. Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.
Broderick MP; Romero-Steiner S; Rajam G; Johnson SE; Milton A; Kim E; Choi LJ; Radin JM; Schmidt DS; Carlone GM; Messonnier N; Faix DJ
Clin Vaccine Immunol; 2016 Aug; 23(8):672-80. PubMed ID: 27280619
[TBL] [Abstract][Full Text] [Related]
45. Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.
Li Y; Zhang Q; Winterbotham M; Mowe E; Gorringe A; Tang CM
Infect Immun; 2006 Nov; 74(11):6348-55. PubMed ID: 16966413
[TBL] [Abstract][Full Text] [Related]
46. Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV.
Pereira-Manfro WF; Alvino RM; Cruz AC; Silva GP; Castro RB; Ferreira B; Barreto DM; Frota AC; Hofer CB; Milagres LG
Vaccine; 2016 Dec; 34(50):6116-6119. PubMed ID: 27847176
[TBL] [Abstract][Full Text] [Related]
47. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines.
Jodar L; Cartwright K; Feavers IM
Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447
[No Abstract] [Full Text] [Related]
48. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
[TBL] [Abstract][Full Text] [Related]
49. Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia.
Ilyina N; Kharit S; Namazova-Baranova L; Asatryan A; Benashvili M; Tkhostova E; Bhusal C; Arora AK
Hum Vaccin Immunother; 2014; 10(8):2471-81. PubMed ID: 25424958
[TBL] [Abstract][Full Text] [Related]
50. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
Frasch CE; Borrow R; Donnelly J
Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
[TBL] [Abstract][Full Text] [Related]
51. Neisseria meningitidis serogroup B: laboratory correlates of protection.
Vermont C; van den Dobbelsteen G
FEMS Immunol Med Microbiol; 2002 Oct; 34(2):89-96. PubMed ID: 12381458
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of immunological responses to recombinant Porin A protein (rPoA) from native strains of Neisseria meningitidis serogroups A and B using OMV as an adjuvant in BALB/c mice.
Afrough P; Bouzari S; Mousavi SF; Asadi Karam MR; Vaziri F; Fateh A; Behrouzi A; Malekan M; Siadat SD
Microb Pathog; 2017 Nov; 112():209-214. PubMed ID: 28942175
[TBL] [Abstract][Full Text] [Related]
53. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
[TBL] [Abstract][Full Text] [Related]
54. Serum opsonins to group B meningococci.
Sjursen H; Bjerknes R; Halstensen A; Naess A; Frøholm LO; Rosenqvist E; Solberg CO
Acta Pathol Microbiol Immunol Scand C; 1987 Dec; 95(6):283-9. PubMed ID: 3126623
[TBL] [Abstract][Full Text] [Related]
55. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
Borrow R; Richmond P; Kaczmarski EB; Iverson A; Martin SL; Findlow J; Acuna M; Longworth E; O'Connor R; Paul J; Miller E
FEMS Immunol Med Microbiol; 2000 May; 28(1):79-85. PubMed ID: 10767611
[TBL] [Abstract][Full Text] [Related]
56. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575
[TBL] [Abstract][Full Text] [Related]
57. Age dependence of in vitro survival of meningococci in whole blood during childhood.
Ison CA; Anwar N; Cole MJ; Pollard AJ; Morley SL; Fidler K; Sandiford C; Banks J; Kroll SJ; Levin M
Pediatr Infect Dis J; 2003 Oct; 22(10):868-73. PubMed ID: 14551486
[TBL] [Abstract][Full Text] [Related]
58. Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
Szenborn L; Block SL; Jackowska T; Konior R; D'Agostino D; Smolenov I; Toneatto D; Welsch JA
Pediatr Infect Dis J; 2018 May; 37(5):475-482. PubMed ID: 29329168
[TBL] [Abstract][Full Text] [Related]
59. Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.
Quiambao BP; Jain H; Bavdekar A; Dubey AP; Kolhe D; Bianco V; Van der Wielen M; Miller JM
Hum Vaccin Immunother; 2016 Aug; 12(8):2162-2168. PubMed ID: 27152501
[TBL] [Abstract][Full Text] [Related]
60. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
